In the evolving landscape of hospice care, the pursuit of clinical excellence is about more than just providing high-quality care. It’s about the seamless integration of every resource a patient requires. That is the rationale for Dragonfly Health’s combined pharmacy and DME offering. By uniting these two critical pillars of care, Dragonfly Health provides hospice teams with a holistic view of the patient experience, driven by data insights and clinical expertise that are unmatched in the industry.
The Power of Clinical Support
At the heart of the Dragonfly Health model is a commitment to clinical support that spans individual patient care, interdisciplinary team development, and enterprise-wide strategic decisions. Dragonfly Health pharmacists serve as an extension of the hospice team, providing expert guidance on complex symptom management, polypharmacy reduction, and the selection of the most effective, evidence-based therapies. They also understand that a patient’s comfort is equally dependent on the equipment they use. In many cases, the right DME choices can reduce the need for medication or even support non-pharmacological interventions. Whether it is the synchronization of respiratory medications with oxygen concentrator settings or the coordination of wound care topicals with specialized support surfaces, Dragonfly Health ensures that clinical pharmacy and DME work in tandem to optimize the patient experience.
Elevating the Interdisciplinary Team
The traditional hospice model often places the burden on nurses and administrators to bridge the gap between their pharmacy provider and their DME vendor. Dragonfly Health removes this fragmentation by providing unified account management and clinical support. This streamlines workflows and ensures that every recommendation—whether a change in a medication profile or the delivery of a specialty bed—is clinically sound and supported by data.
Dragonfly Health’s clinical leaders do more than offer products. They provide actionable insights, assisting hospice partners in understanding the “why” behind utilization patterns, using a unique, combined data set to drive continuous improvement in quality, efficiency, and cost control.
Unmatched Data: The Intersection of Pharmacy and DME
One of the key differentiators for Dragonfly Health lies in the ability to leverage decades of national utilization data across both pharmacy and DME sectors. While many providers analyze these areas in silos, the Dragonfly Health approach treats them as a unified ecosystem.
This vast repository of historical and current data enables several industry-leading capabilities:
- Benchmarking: Hospice organizations gain a clear picture of how their utilization compares to national and regional trends for hospices of similar size and service area, identifying specific opportunities to improve care quality and manage costs more effectively.
- Predictive Analytics: Integrated data allows for sophisticated predictive modeling. By identifying patterns—such as how increases in DME respiratory support often precede changes in medication requirements—clinical teams can stay ahead of patient needs, preventing crises before they occur.
- Holistic Utilization Insights: Dragonfly Health moves beyond simple reporting to demonstrate how the interaction between equipment and pharmacy impacts the total cost of care, inclusive of staff time and other factors that influence current spending and future growth.
A New Standard for Hospice Excellence
Leadership in hospice care requires more than just logistics. It requires a deep understanding of the clinical challenges faced by patients and caregivers. By combining pharmacist-driven medication management with a data-centric approach to DME, Dragonfly Health transforms the way hospice care is managed and delivered. To learn more or schedule a demo, please contact us.